CLASS II ONGOING Device recall · Reported 2 Nov 2022 · FDA Enforcement Report

Aries Sars-CoV-2 Assay recalled by Luminex

Luminex is recalling Aries Sars-CoV-2 Assay, distributed nationwide in the US. The recall was initiated on 14 Sep 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot - Expiration: AB4723A - 05/25/2022, AB5041A - 05/25/2022, AB5060A - 06/01/2022, AB5061A - 06/06/2022, AB5081A - 06/07/2022, AB5139A - 09/10/2022, AB5141A - 09/16/2022, AB5263A - 09/27/2022, AB5282A - 10/05/2022, AB6640A - 06/8/2023, AB6720A - 06/13/2023
Quantity recalled5,141 (24 Cassettes)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0134-2023
FDA event ID
90937
Recalling firm
Luminex, Austin, TX
Classification
Class II
Status
Ongoing
Recall initiated
14 Sep 2022
FDA classified
26 Oct 2022
Reported
2 Nov 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

14 Sep 2022Recall initiated by company
26 Oct 2022Classified by FDA+42 days
2 Nov 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A part defect with the wash 1 syringe of an SARS-CoV-2 assay could lead to incomplete extraction thereby producing an invalid or false negative assay result.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

ARIES SARS-CoV-2 Assay, REF: 50-10047

Where it was distributed

Distribution US nationwide, Indonesia, and Hong Kong.

Nationwide

Questions about this recall

Is Aries Sars-CoV-2 Assay recalled?

Yes. Luminex recalled Aries Sars-CoV-2 Assay on 14 Sep 2022. The recall is Class II and its status is Ongoing. Recall number Z-0134-2023.

Why was it recalled?

A part defect with the wash 1 syringe of an SARS-CoV-2 assay could lead to incomplete extraction thereby producing an invalid or false negative assay result.

Which lots are affected?

Lot - Expiration: AB4723A - 05/25/2022, AB5041A - 05/25/2022, AB5060A - 06/01/2022, AB5061A - 06/06/2022, AB5081A - 06/07/2022, AB5139A - 09/10/2022, AB5141A - 09/16/2022, AB5263A - 09/27/2022, AB5282A - 10/05/2022, AB6640A - 06/8/2023, AB6720A - 06/13/2023

Where was it sold?

Distribution US nationwide, Indonesia, and Hong Kong.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Luminex

All 39

Other Test Kits & Diagnostics recalls

All 2,656